Determination of the Minimal Effective Dosages of Ofloxacin and Sparfloxacin Against M. leprae in the Mouse Foot Pad System

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 64, Issue 2, 1996, Pages 142-145

  Traore, Issa ^a   Ji, Baohong ^b   Lienhardt, Christian ^a   Bobin, Pierre ^a   Grosset, Jacques ^b  

^a Institut Marchoux Mali   (Mali)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OFLOXACIN; SPARFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; FOOT PAD; MOUSE; MYCOBACTERIUM LEPRAE; NONHUMAN;

ANIMALS; ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; FOOT; MICE; MYCOBACTERIUM LEPRAE; OFLOXACIN; QUINOLONES;

EID: 0030017418     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. CHAN, G. P., GARCIA-IGNACIO, B. Y., CHAVEZ, V. E., LIVELO, J. B., JIMENEZ, C. L., PARRILLA, M. L. R. and FRANZBLAU, S. G. Clinical trial of sparfloxacin for lepromatous leprosy. Antimicrob. Agents Chemother. 38 (1994) 61-65.
2. FRANZBLAU, S. G. and WHILE, K. E. Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae. Antimicrob. Agents Chemother. 34 (1990) 229-231.
3. FRANZBLAU, S. G., PARRILLA, L. R. and CHAN, G. P. Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice. Int. J. Lepr. 61 (1993) 66-69.
4. GIDOH, M. and TSUTSUMI, S. Activity of sparfloxacin against Mycobacterium leprae inoculated into foot pads of nude mice. Lepr. Rev. 63 (1992) 108-116.
5. GROSSET, J. H., GUELPA-LAURAS, C. C., PERANI, E. G. and BEOLETTO, C. Activity of ofloxacin against Mycobacterium leprae in the mouse. Int. J. Lepr. 56 (1988) 259-264.
6. GROSSET, J. H., JI, B., GUELPA-LAURAS, C. C., PERANI, E. G. and N'DELI, L. N. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy. Int. J. Lepr. 58 (1990) 281-295.
7. JI, B. and GROSSET, J. H. Recent advances in the chemotherapy of leprosy. Lepr. Rev. 61 (1990) 313-329.
8. JI, B., MATSUO, Y. and COLSTON, M. J. Screening of drugs for activity against Mycobacterium leprae. Int. J. Lepr. 55 (1987) 836-842.
9. JI, B., PERANI, E. G., PETINON, C. and GROSSET, J. H. Bactericidal activities of single and multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. Int. J. Lepr. 60 (1990) 556-561.
10. JI, B., PERANI, E. G., PETINON, C., N'DELI, L. N. and GROSSET, J. H. Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for the treatment of lepromatous leprosy. Antimicrob. Agents Chemother. 38 (1994) 662-667.
11. JI, B., TRUFFOT-PERNOL, C. and GROSSET, J. In vitro and in vivo activities of sparfloxacin (AT-4140) against M. tuberculosis. Tubercle 72 (1991) 181-186.
12. LALANDE, V., TRUFFOT-PERNOT, C., PACCALY-MOULIN, A., GROSSET, J. and JI, B. Powerful bacteńcidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice. Antimicrob. Agents Chemother. 37 (1993) 407-413.
13. SHEPARD, C. C. The experimental disease that follows the injection of human leprosy bacilli into foot pads of mice. J. Exp. Med. 112 (1960) 445-454.
14. TRUFFOT-PERNOT, C., JI, B. and GROSSET, J. Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments. Tubercle 72 (1991) 57-64.